Δ-9,11 modification of glucocorticoids dissociates nuclear factor-κB inhibitory efficacy from glucocorticoid response element-associated side effects.
Baudy AR, Reeves EK, Damsker JM, Heier C, Garvin LM, Dillingham BC, McCall J, Rayavarapu S, Wang Z, Vandermeulen JH, Sali A, Jahnke V, Duguez S, DuBois D, Rose MC, Nagaraju K, Hoffman EP.
Baudy AR, et al. Among authors: garvin lm.
J Pharmacol Exp Ther. 2012 Oct;343(1):225-32. doi: 10.1124/jpet.112.194340. Epub 2012 Jun 28.
J Pharmacol Exp Ther. 2012.
PMID: 22743576
Free PMC article.